Royalty Report: Medical, Device, Diagnostic – Collection: 4805

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 13

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 13

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • cardiac
  • Therapeutic
  • Surgical
  • Catheter

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 4805

License Grant
The Company obtained from Licensor, an individual, a non-exclusive license under an issued U.S. patent for the ALERT® System including the ALERT® Companion and ALERT® internal cardioversion catheters and related disposable supplies like unique one-piece catheter.
License Property
The ALERT® System uses a patented electrode catheter to deliver measured, variable, low-energy bi-phasic electrical impulses directly to the inside of the heart to convert atrial fibrillation to a normal heart rhythm.  The ALERT® Companion is synchronization of a defibrillation shock delivered.

IPSCIO Record ID: 25902

License Grant
Licensor, an individual, granted an exclusive, worldwide License relating to certain technology used in connection with the Alert System for treatment of atrial fibrillation, some of which has since become protected under four issued United States patents.  Under the terms of this License Agreement, Licensee has the right to subLicense this technology to third parties.
License Property
The Alert System uses a patented electrode catheter to deliver measured, variable, low-energy bi-phasic electrical impulses, programmable electrical energy, from one to 15 joules, directly to the inside of the heart to convert atrial fibrillation to normal heart rhythm.

IPSCIO Record ID: 4800

License Grant
The Company an exclusive worldwide license under three issued U.S. patents, an exclusive license under one patent application pending in the European Patent Office and additional filed or licensed patent applications and continuations for the ALERT System with an undisclosed Licensee.
License Property
ALERT System is an atrial fibrillation which uses a patented electrode catheter to deliver measured, variable, low energy electrical impulses directly to the inside of the heart in order to convert atrial fibrillation to a normal heart rhythm.

IPSCIO Record ID: 5656

License Grant
Licensor grants to Licensee a worldwide non exclusive non transferable license under Licensed Technology to make, use, have made or sell Licensed Products.
License Property
Licensed Product(s) means external defibrillator(s) for defibrillating the atria of a heart with temporary catheters and/or heart wires for internal defibrillation which is covered in the country of manufacture and/or sale by one or more claims of a patent included in the Licensed Technology.  Licensor owns the exclusive rights to a U.S. Patent No. 5,207,219 and foreign counterparts thereof (hereinafter referred to as (Licensed Technology).
Field of Use
The rights granted apply to the heart.

IPSCIO Record ID: 163887

License Grant
Assignor sells, assigns, conveys, transfers and delivers to Assignee, its successors and permitted assigns, the Spot Catheter Patents and the Spot Catheter Technology and the Linear Catheter Patents and the Linear Catheter Technology to be used only in the Field of Use.
License Property
Assignor is in the business of developing implantable cardiac defibrillators and electrophysiology catheters. The IP includes patents and U.S. Patent Applications, Serial Nos. 08/496,947 and 09/073,651 and corresponding foreign patents.
Field of Use
The Field of Use shall mean the radio frequency (RF) cardiac ablation therapy field.  This agreement pertains to the medical industry.

IPSCIO Record ID: 5091

License Grant
The Licensee also has the exclusive right to distribute and manufacture the Company’s Trio/Ensemble diagnostic catheters in all territories of the world except southern Europe and Japan.
License Property
The Trio/Ensemble catheters are used for electrophysiological diagnostic mapping of supraventricular tachycardia (SVT), a congenital, rapid heart rhythm that originates above the ventricles in the heart. Using the Trio/Ensemble diagnostic catheters, the electrophysiologist is able to place three catheters through a single patient introduction site rather than having to use three separate introduction sites.  In this way, the Trio/Ensemble provides the electrophysiologist with an overall tool to assess electrical conduction between the atria and the ventricle. Once the SVT is mapped, it can readily be treated using standard radio frequency (RF) catheter ablation techniques to neutralize the heart tissue responsible for the abnormal heart rhythm.
Field of Use
The rights are granted to be used for electrophysiological diagnostic mapping of supraventricular tachycardia (SVT), a congenital, rapid heart rhythm that originates above the ventricles in the heart.

IPSCIO Record ID: 283410

License Grant
The Licensor, a nonprofit American academic medical center,  grants to Company the following (a) an exclusive license with the right to sublicense, within the Field and Territory, under the Patent Rights to make, have made, use, offer for sale, sell, and import Licensed Products; and (b) a nonexclusive license, with the right to sublicense, within the Field and Territory, to use the Know-How to develop, make, have made, use, offer for sale, sell, and import Licensed Products.
License Property
Patent Rights shall mean U.S. patent number 8,538,501, and any re-examinations and re-issues thereof, as well as extensions and supplementary protection certificates and any foreign counterpart of any of the foregoing.

8,538,501 – Mapping and ablation catheter system

Licensed Product shall mean any product, process, or service which (a) the manufacture, use, sale, offer for sale or importation of which infringes an issued claim of the Patent Rights, or that would infringe but for the exception in 35 U.S.C. §271(e)(1), or similar exception in the United States or other countries; or (b) the development, manufacture, use, sale, offer for sale or importation of which incorporates, uses, was derived from, identified by, validated, or developed in whole or in part using the Know-How.

Field of Use
Field shall mean a mapping and ablation catheter system.
Pure EP is a computerized system designed to acquire, digitize, measure, display and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures.
The product sets out to assist electrophysiologists with decision-making during EP procedures in patients with abnormal heart rates and rhythms.

IPSCIO Record ID: 1942

License Grant
The Licensee agreed to license from Licensor, a non-profit health care organization, specific patents relating to Products that treat irregular heartbeats (arrhythmias).
License Property
ICDs are electronic devices that are implanted within the body and are connected to the heart with defibrillator leads.  These devices monitor the patient's heartbeat and, in the event of VT or VF, deliver an electrical shock to return the heartbeat to normal rhythm.

IPSCIO Record ID: 120693

License Grant
A semi-exclusive license under an issued U.S. patent for technology to conduct temporary ventricular defibrillation.
License Property
Defibrillation is a type of abnormal heart rhythm.
Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 257491

License Grant
The parties desire to amend and restate the relationship between the parties that currently exists by virtue of the Exclusive License Agreement dated  January 30, 1973,  to restate the grant to assigned Licensee of the sole and exclusive worldwide license for the use of said patents, patent applications, and inventions.

Licensor grants the sole and exclusive license and right to manufacture, use, sell, rent and lease or otherwise dispose of any and all devices under the Patent Rights and or any Improvements thereof throughout the United States, its territories and possessions, and in any and all foreign countries, subject to the terms and conditions set forth in this Exclusive License Agreement.

License Property
The licensed property includes Implantable Defibrillators, lead devices and other device for use with an Implantable Defibrillator.

Defibrillation is a treatment for life-threatening cardiac dysrhythmias, specifically ventricular fibrillation (VF) and non-perfusing ventricular tachycardia (VT). A defibrillator delivers a dose of electric current (often called a countershock) to the heart.

Field of Use
The field of use is Implantable Defibrillators.  This agreement pertains to the medical industry.

IPSCIO Record ID: 289542

License Grant
If, and only if, Licensor exercises its option for a license under the CIC Patents pursuant to this agreement, Licensor shall grant (and will cause its Affiliates to grant) to Licensee and its Affiliates the right and option until the expiration of thirty (30) months from the Effective Date or ninety (90) days from the date Licensor exercises its option, whichever is later in time, to obtain a non-exclusive, worldwide, non-transferable, royalty-bearing license under the Savacor Patents.
License Property
Savacor Patents shall mean those patents and patent applications, and all patents and patent applications claiming priority therefrom, that Licensor or its Affiliates acquired from Savacor, Ind. as set forth.  The Savacor Patents shall include the sublicensable patents and patent applications of Cedars Sinai Medical Center listed.

6,970,742 – Method for detecting, diagnosing, and treating cardiovascular disease
6,328,699 – Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure

Field of Use
“CRM Products” means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term “CRM Products” includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software. The term “CRM Products” excludes, by way of example and not limitation, nerve stimulators (unless used for cardiac therapy), bone growth stimulators, drug release pumps, cardiac pumps, artificial hearts, prosthetic heart valves, catheter ablation devices, imaging systems, catheter location systems, apparatus for revascularization or correction of other physical defects in heart tissue, arrhythmia mapping devices (except as part of an implantable cardiac therapy or monitoring device), angioplasty devices and EKG monitors (other than cardiac stimulation device programmers or other telemetry devices for use with implantable pulse generators or cardiac monitors) which are standalone, non-ambulatory and not intended for transtelephonic or other remote monitoring.

IPSCIO Record ID: 3394

License Grant
The Licensor granted the Company the exclusive world-wide rights to develop, make and sell the HCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.
License Property
The HCMS will provide the primary measures of cardiac performance and left atrial pressure which are crucial measurements in treating critically ill patients.

5,048,532-Method and Apparatus for Measuring Blood Pressure (S-409)
5,181,517-Method and Apparatus for the Measurement of Atrial Pressure (S-409)

IPSCIO Record ID: 26662

License Grant
Licensor grants to Licensee an exclusive license under its Technology rights to (a) develop, make, have made, use, sell and offer for sale or otherwise exploit the Licensed Products, and (b) use and reproduce Software, create Derivatives, and distribute Software to end-users through the normal channels of distribution, in the Field and Territory during the Term. Licensees will have the unrestricted right to develop Licensee Improvements relating to the Licensed Products in the United States for distribution and exploitation of the Licensed Products either in the United States or outside of the United States. Licensee will also have the unrestricted right to develop Licensee Improvements relating to the Licensed Products in any foreign country for distribution and exploitation of the Licensed Products in any other country, including the U.S.
License Property
Patents relate to develop, make and sell the HCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.

TANGIBLE PROPERTY
1.  One prototype two-balloon esophogeal catheter.

2.  One prototype system control box.

3.  One copy of Source Code.

4.  One laptop with operational Source Code, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

5.  One Dynamap Blood Pressure Monitor, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

6.  One ECG device compatible with the system, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

PATENTS
5,048,532
U.S. Patent
Method and Apparatus for Measuring Blood Pressure (S-409)

5,181,517
U.S. Continuation in Part Patent
Method and Apparatus for the Measurement of Atrial Pressure (S-409)

PCT/US
Corresponds to U.S. 5,181,517
Method and Apparatus for the Measurement of Atrial Pressure (S-409)

91/04504

5,263,485
U.S. Continuation in Part Patent
Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409)

5,398,692
U.S. Continuation in Part Patent
Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409))

5,551,439
U.S. Continuation in Part Patent
Method of Determining a Mean Pressure from a Source within a Body (S-409)

5,570,671
U.S. Continuation in Part Patent
Method for Positioning Esophageal Catheter for Determining Pressures Associated with the Left Atrium (S-409)

5,697,375
U.S. Continuation in Part Patent
Method and Apparatus Utilizing Heart Sounds for Determining Pressure Associated with the Left Atrium (S-409)

5,921,935
U.S. Divisional Patent
Method and Apparatus for Utilizing Heart Sounds For Determining Pressures Associated with the Left Atrium (S-409)

PCT/US
Corresponds to U.S. ‘671, ‘375, ‘935
Method and Apparatus for Determining Pressures Associated with the Left Atrium (S-409)

96/17617

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.